Trials / Terminated
TerminatedNCT00133172
Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection
Evaluation of the Long-term Safety and Efficacy of a Tacrolimus-based 5-day Steroid Rapid Withdrawal Immunoprophylactic Regimen in de Novo Renal Transplantation
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the safety and efficacy of a tacrolimus-based 5-day steroid rapid withdrawal immunoprophylactic regimen in de novo renal transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrolimus | IV |
| DRUG | mycophenolate mofetil | IV |
| DRUG | Prednisone | IV |
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2007-03-01
- Completion
- 2007-03-01
- First posted
- 2005-08-23
- Last updated
- 2014-09-08
Locations
14 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00133172. Inclusion in this directory is not an endorsement.